Review of studies · Supplements / medicine · 18 Oct 2026
Across 7 trials and 608 postmenopausal women, creatine plus resistance training lined up with a small gain in lean mass
Source: Journal of the International Society of Sports Nutrition
What the research found
Study (systematic review and meta-analysis). A review in the Journal of the International Society of Sports Nutrition (DOI 10.1080/15502783.2026.2668435) pooled 7 randomized trials in 608 postmenopausal women, mean age about 62, lasting 12 to 104 weeks (median 38). Lean mass in 5 trials (338 women) favored creatine by 0.37 kg (95 percent CI 0.05 to 0.69). Leg-press strength in 3 trials (111 women) favored creatine by 7.5 kg (2.2 to 12.8). The gain showed up at doses of at least 5 grams a day together with resistance training. Trials at 3 grams a day or less without training did not show a measurable effect. Bone density did not change overall. Side effects were mild and similar to placebo, and kidney lab measures were unchanged. Most trials had some concerns about bias, and the review was not prospectively registered. This is not a reason to start a supplement. Not medical advice. Not a substitute for a prescribed medicine.
Evidence level: Review of studies. This is among the stronger kinds of evidence, but one study rarely settles a question.
Read the original at Journal of the International Society of Sports Nutrition
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34